UNIVERSAL TECHNICAL INSTITUTE INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data UNIVERSAL TECHNICAL INSTITUTE INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	347	324	317	332	301	335	419	607	733	836
Selling, general and administrative	171	145	170	161	149	153	189	256	289	332
Selling and marketing						40.9	54.5	72.2	78.3	88.6
Operating expenses	366	326	352	339	305	320	396	586	674	752
Operating income	-18.6	-1.82	-35.3	-7.8	-3.87	14.9	22.4	21.4	58.9	83.5
Interest expense	3.44	3.38	3.31	3.22	0.01	0.37	2	9.66	9.47	5.63
Interest income	0.24	0.9	1.43	1.49	1.15	0.08	0.51	5.86	6.31	6.17
Other non-operating income	-2.9	-0.91	-0.42	0.14	1.28	0.24	-1.93	-3.31	-2.66	0.81
Pre-tax income	-21.5	-2.73	-35.7	-7.67	-2.59	15.2	20.4	18.1	56.2	84.3
Income tax	26.2	5.4	-3.02	0.2	-10.6	0.6	-5.41	5.77	14.2	21.3
Net income to minority interests	0.53	0.48
Net income	-47.7	-8.13	-32.7	-7.87	8.01	14.6	25.8	12.3	42	63
EBITDA	-3.56	12.4	-22.3	5.42	7.93	29	39.3	46.6	88.2	116
EPS, basic	-2.02	-0.54	-1.51	-0.52	0.05	0.17	0.39	0.13	0.77	1.16
EPS, diluted	-2.02	-0.54	-1.51	-0.52	0.05	0.17	0.38	0.13	0.75	1.13
Shares, basic (weighted)	24.3	24.7	25.1	25.4	29.8	32.8	33.2	34	49.4	54.3
Shares, diluted (weighted)	24.3	24.7	25.1	25.4	30.1	33.1	33.7	34.5	50.9	55.6
Dividend per share	0.04	0.00

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	119	50.1	58.1	65.4	76.8	134	66.5	152	162	127
Short-term investments										41.8
Receivables	15.3	15.2	21.1	17.9	35.4	17.2	16.5	25.2	31.1	46.1
Other current assets	20	9.4	8.03	7.33	6.49	8.07	8.81	7.5	5.24	5.52
Total current assets	162	147	117	118	180	183	136	205	222	247
Property, plant and equipment	114	107	115	104	72.7	122	214	266	265	286
Lease right-of-use assets				0	145	159	132	177	159	179
Goodwill	9.01	9.01	8.22	8.2	8.22	8.22	16.9	28.5	28.5	28.5
Intangible assets						0.12	14.2	19	18.2	17.4
Other non-current assets	12.2	11.6	11.2	10.2	8.57	9.12	5.96	10.8	12.5	23.6
Total assets	297	274	282	271	442	513	553	741	745	826
Accounts payable	11.8	9.52	8.76	10	12.5	13.7	21.7	14.4	26.3	39.1
Accrued liabilities	8.24	11.4	15.8	13.6	11.4	11.2	13.3	15.1	17.1	17.1
Deferred revenue	44.5	41.3	38.2	42.9	40.7	57.6	54.2	85.7	92.5	91.5
Short-term debt					0.13	0.88	1.12	2.52	2.7	2.87
Total current liabilities	94.6	86.4	92.5	96.8	122	133	138	185	205	230
Long-term debt					0.13	29.9	66.4	160	123	84.2
Lease liabilities					134	153	129	165	147	175
Other non-current liabilities	10.7	9.87	10.1	9.58	8.93	7.57	4.07	4.73	4.85	5.14
Total liabilities	161	148	156	156	265	324	338	515	484	498
Total debt					0.26	30.7	67.5	162	126	87.1
Paid-in capital	183	185	187	187	141	142	148	151	221	226
Retained earnings	-17.5	-30.8	-31.6	-44.7	-33	-22	-1.31	5.95	38.5	102
Treasury stock	-97.4	-97.4	-97.4	-97.4	-0.37	-0.37	-0.37	-0.37	-0.37	-0.37
Other comprehensive income	0.02	0	0		0	-0.28	2.21	2.46	1.11	0.91
Shareholders' equity	137	126	127	114	177	189	215	226	260	328
Total equity	137	126	127	114	177	189	215	226	260	328
Total liabilities and equity	297	274	282	271	442	513	553	741	745	826
Shares outstanding	24.6	25	25.3	25.6	32.6	32.8	33.8	34.1	53.8	54.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-47.7	-8.13	-32.7	-7.87	8.01	14.6	25.8	12.3	42	63
Depreciation and amortization	15.1	14.2	13	13.2	11.8	14	16.9	25.2	29.3	33
Stock-based compensation	4.9	2.95	1.82	1.39	2.08	1.73	4.34	3.85	8.56	9.15
Deferred income tax	27.9	0	-2.81	0	0.35	0	-6.01	4.64	4.44	-1.34
Change in receivables	8.2	-2.98	-2.7	-1.48
Change in payables	1.86	-4.76	3.86	2.94	7.02	3.82	7.12	-5.72	13.2	11.2
Cash from operations	7.38	1.15	-13.4	21.7	11	55.2	46	49.1	85.9	97.3
Capital expenditures	-7.5	-8.19	-20.6	-6.45	-9.26	-61.3	-79.5	-56.7	-24.3	-42
Acquisitions	-1.5	0	0		0	0	-26.5	-16.4	0	0
Purchases of investments	0	-42.7	-0.89	0	0
Cash from investing	17.3	-54.4	27.1	-6.15	-45.8	-23	-135	-44.1	-24	-87.9
Debt issued				0	0	31.2	38
Stock issued			0	0	49.2	0	0	0	0	0.66
Share buybacks	0	0
Dividends paid	-1.46	0	0
Cash from financing	64.9	-6.76	-6.58	-7.2	43.1	24.8	12.6	81.8	-51.3	-42.8
Net change in cash	89.6	-68.9	7.2	8.4	8.36	57.1	-76	86.9	10.5	-33.3
Free cash flow	-0.11	-7.04	-34	15.3	1.77	-6.12	-33.4	-7.54	61.6	55.4
Interest paid	3.44	3.38	3.31	3.22	0.01	0.35	1.94	9.07	10.4	5.91
Income taxes paid	1.64	2.7	0.61	0.04			0.86	0.66	10.7	11.3

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $20.30 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	5.0%	Operating income / revenue.
EBITDA margin	9.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.1%	Pre-tax income / revenue.
Net margin	3.9%	Net income / revenue.
FCF margin	-2.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	8.4%	Cash from operations / revenue.
Effective tax rate	24.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	10.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.8%	Net income / average total assets.
Return on invested capital (ROIC)	9.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	43.1%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	11.0%	Capital expenditures / revenue.
D&A / revenue	4.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	14.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	25.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	22.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	41.7%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	55.1%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	32.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	43.7%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	71.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	50.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	34.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	51.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	50.7%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	43.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	86.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	13.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	28.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	54.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-10.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	99.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	26.1%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	15.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	13.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	11.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	14.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	13.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	9.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	18.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	13.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.30x	Current assets / current liabilities.
Quick ratio	1.11x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.86x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.46x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	17.8%	Total debt / total assets.
Liabilities / assets	61.7%	Total liabilities / total assets.
Net debt	-$10.1M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.12x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	11.4x	Operating income / interest expense.
Working capital	$59.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	6.0%	(Goodwill + intangible assets) / total assets.
Tangible book value	$290.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.98x	Revenue / average total assets.
Fixed asset turnover	2.61x	Revenue / average property, plant and equipment.
Receivables turnover	17.7x	Revenue / average receivables.
Days sales outstanding	21 days	365 x average receivables / revenue.
FCF conversion	-66.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	130.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.61	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$15.80	Revenue / diluted weighted shares.
FCF per share	-$0.41	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.33	Cash from operations / diluted weighted shares.
Book value per share	$6.25	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$5.27	Tangible book value / shares outstanding.
Cash per share	$3.09	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$1.12B	Share price x shares outstanding.
Enterprise value	$1.11B	Market cap + total debt - cash - short-term investments.
P/E	32.6x	Market cap / net income. Only when net income is positive.
P/S	1.27x	Market cap / revenue.
P/B	3.25x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.85x	Market cap / tangible book value, when positive.
P/OCF	15.0x	Market cap / cash from operations, when positive.
EV/Sales	1.25x	Enterprise value / revenue.
EV/EBIT	25.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	13.7x	Enterprise value / EBITDA, when both are positive.
FCF yield	-2.0%	Free cash flow / market cap.
Earnings yield	3.1%	Net income / market cap (the inverse of P/E).
PEG	0.74x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was UNIVERSAL TECHNICAL INSTITUTE INC's revenue in fiscal 2025?

UNIVERSAL TECHNICAL INSTITUTE INC reported revenue of $835.6M for fiscal 2025, 14% higher than the year before.

Was UNIVERSAL TECHNICAL INSTITUTE INC profitable in fiscal 2025?

Yes. Net income was $63.0M, a net margin of 7.5%.

How much free cash flow did UNIVERSAL TECHNICAL INSTITUTE INC generate in fiscal 2025?

Cash from operations of $97.3M minus capital expenditures of $42.0M left free cash flow of $55.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to UNIVERSAL TECHNICAL INSTITUTE INC